Terms: = Prostate cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292
95 results:
1. Undiagnosed cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic.
Burus T; Lei F; Huang B; Christian WJ; Hull PC; Ellis AR; Slavova S; Tucker TC; Lang Kuhs KA
JAMA Oncol; 2024 Apr; 10(4):500-507. PubMed ID: 38386344
[TBL] [Abstract] [Full Text] [Related]
2. GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of bmpr1a.
Yang Y; Ding M; Yin H; Chen W; Shen H; Diao W; Yang L; Qin H; Gan W; Qiu X; Guo H
Int J Biol Sci; 2024; 20(4):1297-1313. PubMed ID: 38385080
[TBL] [Abstract] [Full Text] [Related]
3. Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant prostate cancer.
Saylor PJ; Otani K; Balza R; Ukleja J; Pleskow H; Fisher R; Kusaka E; Otani YS; Badusi PO; Smith MR; Meneely E; Olivier K; Lowe AC; Toner M; Maheswaran S; Haber DA; Yeap BY; Lee RJ; Miyamoto DT
JCO Precis Oncol; 2024 Feb; 8():e2300230. PubMed ID: 38354328
[TBL] [Abstract] [Full Text] [Related]
4. prostate cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-Staging System.
Miyamoto H; Teramoto Y; Numbere N; Wang Y; Joseph JV
Mod Pathol; 2024 Mar; 37(3):100429. PubMed ID: 38266919
[TBL] [Abstract] [Full Text] [Related]
5. Improving the diagnostic process for patients with possible bladder and kidney cancer: a mixed-methods study to identify potential missed diagnostic opportunities.
Zhou Y; Singh H; Hamilton W; Archer S; Tan S; Brimicombe J; Lyratzopoulos G; Walter FM
Br J Gen Pract; 2023 Aug; 73(733):e575-e585. PubMed ID: 37253628
[TBL] [Abstract] [Full Text] [Related]
6. Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant prostate cancer (Alliance A031201 Trial).
Morris MJ; Heller G; Hillman DW; Bobek O; Ryan C; Antonarakis ES; Bryce AH; Hahn O; Beltran H; Armstrong AJ; Schwartz L; Lewis LD; Beumer JH; Langevin B; McGary EC; Mehan PT; Goldkorn A; Roth BJ; Xiao H; Watt C; Taplin ME; Halabi S; Small EJ
J Clin Oncol; 2023 Jun; 41(18):3352-3362. PubMed ID: 36996380
[TBL] [Abstract] [Full Text] [Related]
7. Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern.
van der Slot MA; Seyrek N; Kweldam CF; den Bakker MA; Busstra MB; Gan M; Klaver S; Rietbergen JBW; van Leenders GJLH
World J Urol; 2022 Nov; 40(11):2723-2729. PubMed ID: 36190529
[TBL] [Abstract] [Full Text] [Related]
8. Bilateral Seminal Vesicle Invasion Is Not Associated with Worse Outcomes in Locally Advanced prostate Carcinoma.
Vidal Crespo N; Enguita Arnal L; Gómez-Ferrer Á; Collado Serra A; Mascarós JM; Calatrava Fons A; Casanova Ramón-Borja J; Rubio Briones J; Ramírez-Backhaus M
Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013525
[No Abstract] [Full Text] [Related]
9. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
Elife; 2022 Jul; 11():. PubMed ID: 35801699
[TBL] [Abstract] [Full Text] [Related]
10. Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer.
Hadadi A; Smith KE; Wan L; Brown JR; Russler G; Yantorni L; Caulfield S; Lafollette J; Moore M; Kucuk O; Carthon B; Nazha B; Liu Y; Bilen MA
Urol Oncol; 2022 Jun; 40(6):271.e9-271.e18. PubMed ID: 35466038
[TBL] [Abstract] [Full Text] [Related]
11. GSTT1, an increased risk factor for prostate cancer in patients with metabolic syndrome.
Liu D; Che B; Chen P; He J; Mu Y; Chen K; Zhang W; Xu S; Tang K
J Clin Lab Anal; 2022 Apr; 36(4):e24352. PubMed ID: 35293017
[TBL] [Abstract] [Full Text] [Related]
12. Development of a 3D CNN-based AI Model for Automated Segmentation of the Prostatic Urethra.
Belue MJ; Harmon SA; Patel K; Daryanani A; Yilmaz EC; Pinto PA; Wood BJ; Citrin DE; Choyke PL; Turkbey B
Acad Radiol; 2022 Sep; 29(9):1404-1412. PubMed ID: 35183438
[TBL] [Abstract] [Full Text] [Related]
13. Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer.
Hatano K; Yoneyama T; Hatakeyama S; Tomiyama E; Tsuchiya M; Nishimoto M; Yoshimura K; Miyoshi E; Uemura H; Ohyama C; Nonomura N; Fujita K
Br J Cancer; 2022 Mar; 126(5):764-770. PubMed ID: 34802050
[TBL] [Abstract] [Full Text] [Related]
14. The Role of Androgen Receptor Splicing Variant 7 in Predicting the Prognosis of Metastatic Castration-Resistant prostate cancer: Systematic Review and Meta-Analysis.
Liu RJ; Hu Q; Li SY; Mao WP; Xu B; Chen M
Technol Cancer Res Treat; 2021; 20():15330338211035260. PubMed ID: 34313171
[TBL] [Abstract] [Full Text] [Related]
15. Biparametric Magnetic Resonance Imaging-Derived Nomogram to Detect Clinically Significant prostate cancer by Targeted Biopsy for Index Lesion.
Kim MJ; Park SY
J Magn Reson Imaging; 2022 Apr; 55(4):1226-1233. PubMed ID: 34296803
[TBL] [Abstract] [Full Text] [Related]
16. A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer.
Wang X; Bera K; Barrera C; Zhou Y; Lu C; Vaidya P; Fu P; Yang M; Schmid RA; Berezowska S; Choi H; Velcheti V; Madabhushi A
EBioMedicine; 2021 Jul; 69():103481. PubMed ID: 34265509
[TBL] [Abstract] [Full Text] [Related]
17. Nuclear data for reactor production of
Kulage Z; Cantrell T; Griswold J; Denton D; Garland M; Copping R; Mirzadeh S
Appl Radiat Isot; 2021 Jun; 172():109645. PubMed ID: 33689941
[TBL] [Abstract] [Full Text] [Related]
18. prostate MRI characteristics in patients with inflammatory bowel disease.
Takahashi H; Froemming AT; Bruining DH; Karnes RJ; Jimenez RE; Takahashi N
Eur J Radiol; 2021 Feb; 135():109503. PubMed ID: 33418382
[TBL] [Abstract] [Full Text] [Related]
19. [Relationship of ADC histogram parameters with pathological grade and lymph node metastasis of prostate cancer].
Gong ML; Li L; Li K; Li SJ; Wen M
Zhonghua Nan Ke Xue; 2020 Nov; 26(10):881-887. PubMed ID: 33382218
[TBL] [Abstract] [Full Text] [Related]
20. Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized prostate cancer.
Dee EC; Muralidhar V; Arega MA; Kishan AU; Spratt DE; Dess RT; King MT; Sha ST; Santos PMG; Butler SS; Sanford NN; Nguyen PL; Mahal BA
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1279-1285. PubMed ID: 33276019
[TBL] [Abstract] [Full Text] [Related]
[Next]
